Trailing-twelve-month (TTM) revenue is $2.85 Billion with a year-over-year growth of (8.74%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2026Period ended 2025-10-31 | $988,649,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-12-09 |
| Q4 FY2026Period ended 2026-01-31 | $771,488,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-24 |
| Q1 FY2027Period ended 2026-04-30 | $535,962,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-08 |
| Q2 FY2027Period ended 2026-07-31 | $554,093,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-09-08 |
| TTM revenue | $2,850,192,000 |
Current P/S: $1,152,777,245 market capitalization ÷ $2,850,192,000 TTM revenue = 0.40x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:15:25.000Z. Latest revenue period ended 2026-07-31.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2027 (2026-07-31): $554.09M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:17:03.148Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Elimination | N/A | N/A | N/A | N/A | N/A | -$95M |
| Retail | $170M | $118M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-01-31 · USD | FY20222022-01-31 · USD | FY20232023-01-31 · USD | FY20242024-01-31 · USD | FY20252025-01-31 · USD | FY20262026-01-31 · USD |
|---|---|---|---|---|---|---|
| Non-United States | N/A | $401M | $617M | $698M | $719M | N/A |
| Non-US | N/A | N/A | N/A |
$2.85B
$2.85 Billion
(8.74%)
vs. $3.12B a year ago (TTM)
+3.88%
5 Year compound annual growth rate
1 Year
(8.74%)
3 Year
(3.78%)
5 Year
+3.88%
10 Year
+1.10%
15 Year
+6.26%
20 Year
+12.92%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $2.96B | ($223.78M) | (7.04%) |
| 2025 | $3.18B | +$82.55M | +2.66% |
| 2024 | $3.10B | ($128.49M) | (3.98%) |
| 2023 | $3.23B | +$460.19M | +16.63% |
| 2022 | $2.77B | +$711.39M | +34.62% |
| 2021 |
TTM Growth
(8.74%)
3-Year CAGR
(3.78%)
5-Year CAGR
+3.88%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:17:03.148Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $148M |
| $166M |
| $186M |
| Wholesale operations | $1.9B | $2.7B | $3.2B | $3.0B | $3.1B | $2.9B |
|---|
| N/A |
| N/A |
| $672M |
| Other Geographic Region | $299M | N/A | N/A | N/A | N/A | N/A |
|---|
| United States | N/A | $2.4B | $2.6B | $2.4B | $2.5B | $2.3B |
|---|
| $2.06B |
| ($1.11B) |
| (34.97%) |
| 2020 | $3.16B | +$84.26M | +2.74% |
| 2019 | $3.08B | +$269.27M | +9.59% |
| 2018 | $2.81B | +$420.50M | +17.62% |
| 2017 | $2.39B | +$42.29M | +1.80% |
